Q1经营明显改善，业绩实现扭亏

Investment Rating - The report maintains a "Buy-A" investment rating for the company, with a target price of 39.04 CNY per share over the next six months [4][21]. Core Insights - The company reported a revenue of 1.27 billion CNY for 2023, representing a year-over-year increase of 42.3%. The net profit attributable to shareholders was -50 million CNY, an improvement from a loss of 120 million CNY in the previous year [2]. - In Q1 2024, the company achieved a revenue of 290 million CNY, up 28.6% year-over-year, and a net profit of 20 million CNY, compared to a loss of 1.82 million CNY in the same period last year [2]. - The company has shown continuous improvement in profitability, with net profit margins of -10.4% in Q4 2023 and 5.3% in Q1 2024, reflecting a year-over-year increase of 16.7 percentage points and 6.1 percentage points, respectively [3]. - The company is focusing on optimizing its product offerings and channel strategies, particularly on Douyin, which has significantly contributed to revenue growth [19]. Financial Summary - The company’s revenue is projected to grow from 1.62 billion CNY in 2024 to 2.49 billion CNY in 2026, with net profits expected to turn positive in 2024 at 110 million CNY and reach 200 million CNY by 2026 [8]. - The earnings per share (EPS) are forecasted to be 1.30 CNY in 2024, 1.84 CNY in 2025, and 2.34 CNY in 2026 [4][8]. - The company’s gross margin is expected to improve, with a projected net profit margin of 6.9% in 2024, increasing to 8.1% by 2026 [8]. Market Position and Growth Potential - The small massage device industry is anticipated to have strong growth potential, with significant room for market expansion and increased concentration [4]. - The company has been in the industry for twenty years, leveraging its product, channel, and brand advantages to lead market development [4]. - The introduction of new products has been successful, with new product revenue accounting for 58.9% of total revenue in 2023, up from 32.5% the previous year [19].